Home Compare JAZZ vs PUB.PA
Stock Comparison · Single-driver result

Jazz Pharmaceuticals vs Publicis Groupe: Which Stock Looks Stronger in 2026?

Publicis Groupe holds the cleaner structural position, with profitability as the main driver and growth adding further support. In the market, Jazz Pharmaceuticals carries the stronger setup — intact trend against Publicis Groupe's broken trend. That leaves a split case: the structural lead stays with Publicis Groupe, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Profitability still does most of the heavy lifting in this comparison. Publicis Groupe S.A. leads by 9 points on the overall comparison score.

Trajectory Similarity
0.68
Moderately similar
Peer-set rank: #6
within Jazz Pharmaceuticals plc's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The match is driven mainly by revenue stability and investment intensity.

Similarity drivers
revenue stabilityinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
JAZZ
Jazz Pharmaceuticals plc
56
Peer-Score
Signal qualityHigh
vs
PUB.PA
Publicis Groupe S.A.
65
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: JAZZ vs PUB.PA Profitability 35 66 Stability 44 36 Valuation 88 86 Growth 48 59 JAZZ PUB.PA
Gap Ranking
#1 Profitability +31
#2 Growth +11
#3 Stability +8
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for JAZZ and PUB.PA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer JAZZPUB.PA Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Publicis Groupe S.A. ranks near the top of the group on profitability; Jazz Pharmaceuticals plc sits in the weaker half.
Growth
On growth, the same pattern holds: both rank well, but Publicis Groupe S.A. still sits higher.
Profitability — Dominant Gap
JAZZ
35
PUB.PA
66
Gap+31in favour of PUB.PA

Capital efficiency adds support, with a 17.9-point ROIC advantage.

What keeps the gap from being one-sided

On the market side, Jazz Pharmaceuticals carries the stronger trend while Publicis Groupe's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

Profitability is the clearest driver, and growth also supports Publicis Groupe S.A.'s broader structural position.

Explore full peer positioning in AssetNext

Break down the JAZZ vs PUB.PA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-driven comparisons

Explore how JAZZ and PUB.PA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.